Duncan Walker
Impact in
- Cell Biology top 5%
- Microtubule and mitosis dynamics
- Hematology top 5%
- Multiple Myeloma Research and Treatments
Papers in
-
- Protein Degradation and Inhibitors 12
- Ubiquitin and proteasome pathways 10
- Histone Deacetylase Inhibitors Research 3
- PI3K/AKT/mTOR signaling in cancer 3
- Oncology 12
- Cancer-related Molecular Pathways 7
- Co-authors
- James L. Maller (1 shared paper)Linda J. Pike (3 shared papers)Brian Tunquist (8 shared papers)Sherilyn Goldstone (1 shared paper)Simon J. Conn (1 shared paper)Stephen Dalton (1 shared paper)Peter D. Rathjen (1 shared paper)Renate Faast (1 shared paper)
- Journals
- Blood (12 papers)Cancer Research (9 papers)Molecular Cancer Therapeutics (4 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Biochemistry (2 papers)
- Partner nations
- United StatesAustraliaSwitzerland
In The Last Decade
Duncan Walker
39 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 89
- Cell Biology 307
- Hematology 197
- Oncology 338
- Molecular Biology 872
- Aging 17
Countries citing papers authored by Duncan Walker
This map shows the geographic impact of Duncan Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duncan Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duncan Walker more than expected).
Fields of papers citing papers by Duncan Walker
This network shows the impact of papers produced by Duncan Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duncan Walker. The network helps show where Duncan Walker may publish in the future.
Co-authors
The 25 scholars most cited alongside Duncan Walker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 307 | |
| 2 | 1991 | 191 | |
| 3 | 2020 | 116 | |
| 4 | 2009 | 110 | |
| 5 | 1988 | 67 | |
| 6 | 2010 | 59 | |
| 7 | ARRY-520, a novel KSP inhibitor with potent activity in hematological and taxane-resistant tumor models. | 2009 | 53 |
| 8 | 2017 | 48 | |
| 9 | 2016 | 33 | |
| 10 | 1987 | 31 | |
| 11 | 2013 | 27 | |
| 12 | 2002 | 24 | |
| 13 | 2012 | 21 | |
| 14 | 2002 | 11 | |
| 15 | 2018 | 11 | |
| 16 | 2012 | 10 | |
| 17 | 2011 | 10 | |
| 18 | 2008 | 10 | |
| 19 | 1990 | 10 | |
| 20 | SNS-032 is a potent and selective inhibitor of CDK2, 7 and 9 and induces cell death by inhibiting cell cycle progression and the expression of antiapoptotic proteins | 2006 | 9 |
About Duncan Walker
Duncan Walker is a scholar working on Molecular Biology, Oncology, Hematology, Cell Biology and Genetics, having authored 42 papers that have together received 1.2k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (12 papers), Multiple Myeloma Research and Treatments (12 papers), Ubiquitin and proteasome pathways (10 papers), Microtubule and mitosis dynamics (8 papers), Cancer-related Molecular Pathways (7 papers), Histone Deacetylase Inhibitors Research (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Click Chemistry and Applications (2 papers). The work is most often cited by research in Cell Biology (307 citations), Hematology (197 citations), Oncology (338 citations), Molecular Biology (872 citations) and Aging (17 citations). Duncan Walker has collaborated with scholars based in United States, Australia and Switzerland. Frequent co-authors include James L. Maller, Linda J. Pike, Brian Tunquist, Sherilyn Goldstone, Simon J. Conn, Stephen Dalton, Peter D. Rathjen, Renate Faast, Joy Rathjen and Richard Woessner. Their work appears in journals such as Blood, Cancer Research, Molecular Cancer Therapeutics, Bioorganic & Medicinal Chemistry Letters and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.